Economic evaluation of the sFlt-1/PlGF ratio for the short-term prediction of preeclampsia in a Japanese cohort of the PROGNOSIS Asia study
Open Access
- 16 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Hypertension Research
- Vol. 44 (7), 822-829
- https://doi.org/10.1038/s41440-021-00624-2
Abstract
The PRediction of short-term Outcomes in preGNant wOmen with Suspected preeclampsIa Study (PROGNOSIS) Asia validated the use of the soluble fms-like tyrosine 1/placental growth factor (sFlt-1/PlGF) ratio cutoff value of ≤38 to rule out the occurrence of preeclampsia in the short term in Asian women. We assessed the economic impact of the introduction of the sFlt-1/PlGF ratio test for predicting preeclampsia in Japan using data from the Japanese cohort of PROGNOSIS Asia. The cost analysis was developed with estimates in either a no-test scenario, with clinical decisions based on standard diagnostic procedures alone, or a test scenario, in which the sFlt-1/PlGF ratio test was used in addition to standard diagnostic procedures. For both scenarios, rates of hospitalization and other test characteristics were obtained from the results for the Japanese cohort in PROGNOSIS Asia. The total cost per patient was the main outcome of this cost analysis model. Introduction of the sFlt-1/PlGF ratio test using a cutoff value of 38 resulted in a reduced hospitalization rate compared with the rate in the no-test scenario (14.4% versus 8.7%). The reduction in the rate of hospitalizations led to an estimated 16 373 JPY reduction in healthcare costs per patient. The sFlt-1/PlGF ratio test is likely to reduce the unnecessary hospitalization of women at low risk of developing preeclampsia in the short term while also identifying high-risk individuals requiring appropriate management. Reducing unnecessary hospitalizations would result in significant cost savings in the Japanese healthcare system.Keywords
This publication has 34 references indexed in Scilit:
- Hypertensive disease of pregnancy and maternal mortalityCurrent Opinion in Obstetrics and Gynecology, 2013
- Comparison of risk factors for gestational hypertension and preeclampsia in Japanese singleton pregnanciesJournal of Obstetrics and Gynaecology Research, 2012
- The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patientsAmerican Journal of Obstetrics and Gynecology, 2012
- Maternal death analysis from the Japanese autopsy registry for recent 16 years: significance of amniotic fluid embolismJournal of Obstetrics and Gynaecology Research, 2010
- An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2010
- Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsiaHypertension Research, 2010
- The Global Impact of Pre-eclampsia and EclampsiaSeminars in Perinatology, 2009
- Utilization of Health Care Services of Pregnant Women Complicated by Preeclampsia in OntarioHypertension in Pregnancy, 2009
- Soluble Endoglin and Other Circulating Antiangiogenic Factors in PreeclampsiaThe New England Journal of Medicine, 2006
- Circulating Angiogenic Factors and the Risk of PreeclampsiaThe New England Journal of Medicine, 2004